cardinal health glp-1 receptor agonist weight management diabetes treatments New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight GLP-1 for Diabetes vs GLP-1

Pros: Long track record of safety

Greater Satiety Does Not Mean Better Nutrition Many people describe an experience like this: I simply dont feel like eating anymore. Although this may initially seem like an advantage, it can also lead to diets that are deficient in fiber, vitamins, and minerals

Restoring energy with NAD+ For some, that means restoring energy

While this isn't a direct rejection of the drug's potential, it does mean a delay for patients and families hoping for a higher-dose option

Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity